Arseny Moralev
5PUBLICATIONS
12CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Dec 30, 2025
Soloxolone N-3-(Dimethylamino)propylamide Suppresses Tumor Growth and Mitigates Doxorubicin-Induced Hepatotoxicity in RLS40 Lymphosarcoma-Bearing Mice.Arseny D Moralev, Aleksandra V Sen'kova, Alina A Firsova
|Dec 30, 2025
Reversing the Irreversible: miRNA-Targeting Mesyl Phosphoramidate Oligonucleotides Restore Sensitivity to Cisplatin and Doxorubicin of KB-8-5 Epidermoid Carcinoma Cells.Svetlana Miroshnichenko, Rabia Demirel, Arseny Moralev
|Oct 29, 2025
Novel Cross-Cancer Hub Genes in Doxorubicin Resistance Identified by Transcriptional Mapping.Arseny D Moralev, Oleg V Markov, Marina A Zenkova
|Jan 25, 2025
Sesquiterpene Lactones as Promising Anti-Glioblastoma Drug Candidates Exerting Complex Effects on Glioblastoma Cell Viability and Proneural-Mesenchymal Transition.Andrey V Markov, Arseny D Moralev, Kirill V Odarenko
|Oct 26, 2024
Soloxolone N-3-(Dimethylamino)propylamide Restores Drug Sensitivity of Tumor Cells with Multidrug-Resistant Phenotype via Inhibition of P-Glycoprotein Efflux Function.Arseny D Moralev, Oksana V Salomatina, Nariman F Salakhutdinov
Pageof 1
Frequent Collaborators
5 joint publications
Andrey V Markov
4 joint publications
Marina Zenkova
1 joint publications
Kirill V Odarenko
1 joint publications
Oleg V Markov
1 joint publications
Aleksandra V Sen'kova
1 joint publications
Artem D Rogachev
1 joint publications
Svetlana Miroshnichenko
1 joint publications
Rabia Demirel
1 joint publications
Olga Almieva
1 joint publications
Dmitry Stetsenko
